In clinical trials, a trend toward improved final height with GH co-treatment was observed but did not reach statistical significance (WMD = 2.14 cm, 95% CI: –0.14 to 4.43; P = 0.07).
← all excerpts
Efficacy of combined gonadotropin-releasing hormone analogue and growth hormone therapy in girls with central precocious puberty: a systematic review and meta-analysis.
1
0.0700
0.0700